198 related articles for article (PubMed ID: 32991174)
1. Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates.
Jia X; Weber S; Schols D; Meier C
J Med Chem; 2020 Oct; 63(20):11990-12007. PubMed ID: 32991174
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
Zhao C; Weber S; Schols D; Balzarini J; Meier C
Angew Chem Int Ed Engl; 2020 Dec; 59(49):22063-22071. PubMed ID: 32379948
[TBL] [Abstract][Full Text] [Related]
3. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
Weinschenk L; Gollnest T; Schols D; Balzarini J; Meier C
ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
[TBL] [Abstract][Full Text] [Related]
4. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
Zhao C; Jia X; Schols D; Balzarini J; Meier C
ChemMedChem; 2021 Feb; 16(3):499-512. PubMed ID: 33089929
[TBL] [Abstract][Full Text] [Related]
5. The DiPPro approach: synthesis, hydrolysis, and antiviral activity of lipophilic d4T diphosphate prodrugs.
Schulz T; Balzarini J; Meier C
ChemMedChem; 2014 Apr; 9(4):762-75. PubMed ID: 24616176
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds.
Jia X; Schols D; Meier C
Adv Sci (Weinh); 2023 Dec; 10(36):e2306021. PubMed ID: 37884485
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents.
Keane SJ; Ford A; Mullins ND; Maguire NM; Legigan T; Balzarini J; Maguire AR
J Org Chem; 2015 Mar; 80(5):2479-93. PubMed ID: 25532055
[TBL] [Abstract][Full Text] [Related]
8. Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals.
Gollnest T; de Oliveira TD; Schols D; Balzarini J; Meier C
Nat Commun; 2015 Oct; 6():8716. PubMed ID: 26503889
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of the α-carboxyphosphonate moiety in the HIV-RT activity of α-carboxy nucleoside phosphonates.
Mullins ND; Maguire NM; Ford A; Das K; Arnold E; Balzarini J; Maguire AR
Org Biomol Chem; 2016 Feb; 14(8):2454-65. PubMed ID: 26813581
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside mono- and diphosphate prodrugs of 2',3'-dideoxyuridine and 2',3'-dideoxy-2',3'-didehydrouridine.
Pertenbreiter F; Balzarini J; Meier C
ChemMedChem; 2015 Jan; 10(1):94-106. PubMed ID: 25209965
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and substrate properties towards HIV-1 reverse transcriptase of new diphosphate analogues of 9-[(2-phosphonomethoxy)ethyl]adenine.
Laux WH; Priet S; Alvarez K; Peyrottes S; Périgaud C
Antivir Chem Chemother; 2018; 26():2040206618757636. PubMed ID: 29436843
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.
Jia X; Schols D; Meier C
J Med Chem; 2020 Jul; 63(13):6991-7007. PubMed ID: 32515595
[TBL] [Abstract][Full Text] [Related]
14. γ-Ketobenzyl-Modified Nucleoside Triphosphate Prodrugs as Potential Antivirals.
Nack T; Dinis de Oliveira T; Weber S; Schols D; Balzarini J; Meier C
J Med Chem; 2020 Nov; 63(22):13745-13761. PubMed ID: 33186038
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of 2'-fluorine modified nucleoside phosphonates: analogs of GS-9148.
Mackman RL; Lin KY; Boojamra CG; Hui H; Douglas J; Grant D; Petrakovsky O; Prasad V; Ray AS; Cihlar T
Bioorg Med Chem Lett; 2008 Feb; 18(3):1116-9. PubMed ID: 18082402
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-Active Nucleoside Triphosphate Prodrugs.
Jia X; Schols D; Meier C
J Med Chem; 2020 Jun; 63(11):6003-6027. PubMed ID: 32421343
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?
Meier C
Antivir Chem Chemother; 2017 Dec; 25(3):69-82. PubMed ID: 29096525
[TBL] [Abstract][Full Text] [Related]
18. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C
Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel distamycin-modified nucleoside analogues as HIV-1 reverse transcriptase inhibitors.
Li C; Ma C; Zhang J; Qian N; Ding J; Qiao R; Zhao Y
Antiviral Res; 2014 Feb; 102():54-60. PubMed ID: 24342709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
